Role of p53 Pathway Alterations in Uterine Carcinosarcomas (Malignant Mixed Müllerian Tumors)

Publisher： Karger

E-ISSN： 1423-0232|87|4|193-204

ISSN： 0030-2414

Source： Oncology, Vol.87, Iss.4, 2014-07, pp. : 193-204

Disclaimer: Any content in publications that violate the sovereignty, the constitution or regulations of the PRC is not accepted or approved by CNPIEC.

Previous Menu Next

Abstract

Related content

Synchronous uterine MMMT and ovarian TCC

By  

JOURNAL OF OBSTETRICS AND GYNAECOLOGY RESEARCH (ELECTRONIC), Vol. 41, Iss. 2, 2015-02 ,pp. : 319-323

John Wiley & Sons Inc

Access to resources Recommend Favorite

Malignant Mixed Müllerian Tumour of the Uterus: Analysis of 44 Cases

By  

Oncology, Vol. 92, Iss. 4, 2017-01 ,pp. : 197-204

Karger

Access to resources Recommend Favorite

p53 Alterations in Myeloid Leukemia

By  

Acta Haematologica, Vol. 111, Iss. 1-2, 2003-12 ,pp. : 100-106

Karger

Access to resources Recommend Favorite

Primary Peritoneal Malignant Mixed Müllerian Tumor in a Young Woman: Achieving the Best Clinical Benefit

By  

Case Reports in Oncology, Vol. 2, Iss. 3, 2009-09 ,pp. : 162-167

Karger

Access to resources Recommend Favorite

TP53/p53 alterations and Aurora A expression in progressor and nonprogressor colectomies from patients with longstanding ulcerative colitis

By  

International Journal of Molecular Medicine, Vol. 35, Iss. 1, 2015-01 ,pp. : 24-30

Spandidos Publications

Access to resources Recommend Favorite